Colinz Laboratories Ltd — Important, 03-04-2026: Company Update

Colinz Laboratories Limited has informed the exchange that it is exempt from submitting Related Party Transaction (RPT) disclosures. Citing Regulation 15(2)(a) of SEBI's Listing Obligations and Disclosure Requirements, the company states that provisions related to RPT disclosures do not apply to them. Consequently, Colinz is not required to submit RPT disclosures for the quarter that ended March 31, 2026. This simplifies the company's compliance requirements, as it is relieved from a specific regulatory filing obligation, impacting its administrative workload.